Results 1 to 10 of about 360,786 (304)

Microchimerism in Graves’ Disease [PDF]

open access: yesJournal of Thyroid Research, 2012
Microchimerism is the presence of cells from one individual in another genetically distinct individual. Pregnancy is the main cause of natural microchimerism through transplacental bidirectional cell trafficking between mother and ...
Galofre, J.C. (Juan Carlos)
core   +6 more sources

Graves’ disease [PDF]

open access: yesNature Reviews Disease Primers, 2020
Graves' disease (GD) is an autoimmune disease that primarily affects the thyroid gland. It is the most common cause of hyperthyroidism and occurs at all ages but especially in women of reproductive age. Graves' hyperthyroidism is caused by autoantibodies to the thyroid-stimulating hormone receptor (TSHR) that act as agonists and induce excessive ...
Davies, Terry F.   +8 more
  +9 more sources

Radioactive iodine in the treatment of Graves' disease: history and modern concept of radionuclide therapy [PDF]

open access: yesТерапевтический архив, 2022
Radioactive iodine 131I is a theranostic isotope used both for diagnosis and therapy of benign thyroid diseases and thyroid cancer for 85 years. The formation of nuclear medicine is closely linked with the use of 131I.
Marina S. Sheremeta   +3 more
doaj   +1 more source

What kind of therapeutic solutions for Graves’ disease does modern medicine propose? - a review of the literature

open access: yesJournal of Education, Health and Sport, 2023
Background: Graves' disease is responsible for 60-80% causes of hyperthyreosis. An important role in the pathogenesis is played by anti-TSHR immunoglobulins (TRAb), that stimulate TSH receptors leading to excessive hormone synthesis and release by the ...
Natalia Woś   +9 more
doaj   +1 more source

Long-term management of Graves disease: a narrative review [PDF]

open access: yesJournal of Yeungnam Medical Science, 2023
Graves disease (GD) is the most common cause of hyperthyroidism, accounting for more than 90% of cases in Korea. Patients with GD are treated with any of the following: antithyroid drugs (ATDs), radioactive iodine (RAI) therapy, or thyroidectomy.
Hyo-Jeong Kim
doaj   +1 more source

The Occurrence of a Thyroid Storm in a Patient with Recurrent Refractory Peptic Ulcer: A Case Report [PDF]

open access: yesJournal of Acute Care Surgery, 2022
A thyroid storm is a rare complication of hyperthyroidism. Although a thyroid storm rarely presents with symptoms similar to those of an acute abdomen, and in cases where emergency surgery is needed, the thyroid function test is not performed routinely ...
Kwanhoon Park, Ji Young Jang, Sungho Lee
doaj   +1 more source

Graves-Basedow disease and potential risk factors [PDF]

open access: yesVojnosanitetski Pregled, 2008
Background/Aim. Graves-Basedow disease is a common multifactorial genetic syndrome, which is determined by several genes and environmental factors. The aim of the present study was to investigate the presence of risk factors for developing Graves-Basedow
Živanović Dušica   +3 more
doaj   +1 more source

A Case of Thyrotoxic Periodic Paralysis and Graves’ Ophthalmopathy Patient in Coincidence with Chronic Hepatitis B Infection

open access: yesThe Indonesian Journal of Gastroenterology, Hepatology and Digestive Endoscopy, 2022
Graves' disease is an autoimmune thyroid disease with several characteristic symptoms and signs. Graves' ophthalmopathy, an inflammatory disease in the orbital area, is the main extrathyroid manifestation of Graves' disease.
Herry Krisnata Ginting, Soebagijo Adi
doaj   +1 more source

Updates in the Management of Graves Disease in Children

open access: yesThe Ewha Medical Journal, 2023
Graves disease (GD) is the primary cause of hyperthyroidism in children. The standard management options—namely, antithyroid drugs (ATD), radioactive iodine, and surgery—have not changed for many years.
Yun Jeong Lee
doaj   +1 more source

Antithyroid Drug Treatment in Graves’ Disease [PDF]

open access: yesEndocrinology and Metabolism, 2021
Graves’ disease is associated with thyrotropin (TSH) receptor stimulating antibody, for which there is no therapeutic agent. This disease is currently treated through inhibition of thyroid hormone synthesis or destruction of the thyroid gland. Recurrence
Jae Hoon Chung
doaj   +1 more source

Home - About - Disclaimer - Privacy